-
公开(公告)号:ES2618929T3
公开(公告)日:2017-06-22
申请号:ES12710841
申请日:2012-03-13
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA , BINCH HAYLEY , DENINNO MICHAEL , FANNING LEV , FRIEMAN BRYAN , GROOTENHUIS PETER , HILGRAF NICOLE , JOSHI PRAMOD , KALLEL EDWARD , PONTILLO JOSEPH , SILINA ALINA , SHETH URVI , HURLEY DENNIS , ARUMUGAM VIJAYALAKSMI , MILLER MARK
IPC: C07D498/10 , A61K31/424 , A61P29/00
Abstract: Un compuesto de fórmula I:**Fórmula** o una sal farmacéuticamente aceptable del mismo, en la que, independientemente para cada caso: R1 es alquilo C1-C6, fluoroalquilo C1-C6, cicloalquilo C3-C8, halo, NR8SO2R8, SO2R8, SR8, SOR8, NR8COR8, NR8CO2R8, CN, CON(R8)2, SO2N(R8)2, CF3, heterocicloalquilo, fenilo, heteroarilo, o una cadena lineal, ramificada o cíclica (C1-C8)-R9 en donde hasta dos unidades CH2 pueden reemplazarse con O, CO, S, SO, SO2, N, CF2, o NR8; R2 es alquilo C1-C6, alquilo C1-C6, fluoroalquilo, cicloalquilo, arilo, heteroarilo, o heterocicloalquilo, COR8, CO2R8, CON(R8)2, CF3, CHF2, o una cadena lineal, ramificada, o cíclica (C1-C8)-R9 en la que hasta dos unidades CH2 pueden reemplazarse por O, CO, S, SO, SO2, N, CF2, o NR8; R3 es alquilo C1-C6 o halo; R8es H, alquilo C1-C6, o cicloalquilo C3-C8, de cadena lineal, ramificada o cíclica (C1-C8)-R9 en la que hasta dos unidades CH2 pueden reemplazarse por O, CO, S, SO, SO2, N, CF2, o NR, O2R8 tomados junto con los átomos a los que están unidos forman un anillo; R9 es H, CF3, CHF2, CH2F, CO2R, OH, arilo, heteroarilo, cicloalquilo Cicloalquilo C3-C8, heterocicloalquilo, N(R)2, NRCOR, CON(R)2, CN,O SO2R; R es H, alquilo C1-C6, arilo, heteroarilo, cicloalquilo C3-C8, o heterocicloalquilo; A es un arilo, heteroarilo o heterocíclico; n es un número entero de 1 a 4 inclusive; y o es un número entero de 0 a 4 inclusive; donde cada alquilo, fluoroalquilo, cicloalquilo, heterocicloalquilo, fenilo, heteroarilo, cicloalquilo C3-C8, o arilo de R1 a R8 se sustituye ontionalmente con uno o más sustituyentes seleccionados de halo, ciano, oxoalcoxi, hidroxi, amino, nitro, arilo, haloalquilo, y alquilo.
-
公开(公告)号:ES2532138T3
公开(公告)日:2015-03-24
申请号:ES09753253
申请日:2009-10-23
Applicant: VERTEX PHARMA
Inventor: BINCH HAYLEY , FANNING LEV , BOTFIELD MARTYN , GROOTENHUIS PETER , VAN GOOR FREDRICK , NUMA MEHDI
IPC: C07D487/08 , A61K31/4709 , A61P11/00 , A61P43/00
Abstract: Compuesto de Fórmula I **Fórmula** o sales farmacéuticamente aceptables del mismo, en la que: el anillo A está seleccionado de entre:**Fórmula** en elque: R1 es -CH3, -CF3 o -CN; R2 es hidrógeno, -CH3, -CF3, -OH o -CH2OH; R3 es hidrógeno, -CH3, -OCH3 o -CN; Ra es hidrógeno o un grupo protector de sililo seleccionado del grupo que consiste en trimetilsililo (TMS), terc-butildifenilsililo (TBDPS), terc-butildimetilsililo (TBDMS), triisopropilsililo (TIPS) y [2-(trimetilsilil)etoxi]metilo(SEM); siempre que R2 y R3 no sean simultáneamente hidrógeno; y uno entre X e Y es nitrógeno y el otro es carbono.
-
公开(公告)号:AT435214T
公开(公告)日:2009-07-15
申请号:AT05807734
申请日:2005-08-31
Applicant: VERTEX PHARMA
Inventor: WILSON DEAN , TERMIN ANDREAS , GONZALEZ JESUS , FANNING LEV , NEUBERT TIMOTHY , KRENITSKY PAUL , JOSHI PRAMOD , HURLEY DENNIS , SHETH URVI , BOGER JOSHUA
IPC: C07D239/94 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12
Abstract: The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
-
公开(公告)号:AU2016203414A1
公开(公告)日:2016-06-23
申请号:AU2016203414
申请日:2016-05-25
Applicant: VERTEX PHARMA
Inventor: CHARRIER JEAN-DAMIEN , DURRANT STEVEN , KAY DAVID , O'DONNELL MICHAEL , KNEGTEI RONALD , MACCORMICK SOMHAIRLE , PINDER JOANNE , VIRANI ANISA , YOUNG STEPHEN , BINCH HAYLEY , CLEVELAND THOMAS , FANNING LEV , HURLEY DENNIS , JOSHI PRAMOD , SHETH URVI , SILINA ALINA
IPC: C07D401/04 , A61K31/4965 , A61P35/00 , C07D403/04 , C07D413/04
Abstract: Abstract The present invention relates to pyrazine compounds, pharmaceutical compositions comprising them, and methods for inhibiting ATR protein kinase for treating various diseases, disorders, and conditions including cancer, HIV, hepatitis, adenovirus and psoriasis. Additionally the invention discloses processes for preparing the compounds, intermediates used in the preparation, and methods of using the compounds in in vitro applications including the study of kinases in biological and pathological phenomena, the study of intracellular signal transduction pathways mediated by such kinases, and the comparative evaluation of new kinase inhibitors.
-
公开(公告)号:AU2005282761B2
公开(公告)日:2012-02-02
申请号:AU2005282761
申请日:2005-08-31
Applicant: VERTEX PHARMA
Inventor: TERMIN ANDREAS P , HURLEY DENNIS J , BOGER JOSHUA S , KRENITSKY PAUL , FANNING LEV , WILSON DEAN , GONZALEZ JESUS E III , JOSHI PRAMOD , SHETH URVI , NEUBERT TIMOTHY D
IPC: C07D239/94 , A61K31/498 , A61P9/06 , A61P25/00 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14
Abstract: The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
-
公开(公告)号:AT453629T
公开(公告)日:2010-01-15
申请号:AT04716887
申请日:2004-03-03
Applicant: VERTEX PHARMA
Inventor: GONZALES JESUS , WILSON DEAN , TERMIN ANDREAS , GROOTENHUIS PETER , ZHANG YULIAN , PETZOLDT BENJAMIN , FANNING LEV , NEUBERT TIMOTHY , TUNG ROGER , MARTINBOROUGH ESTHER , ZIMMERMANN NICOLE
IPC: C07D239/94 , A61K31/517 , A61K31/5377 , A61K31/541 , C07D20060101 , C07D239/91 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/02 , C07D413/12 , C07D417/02 , C07D417/12 , C07D417/14 , C07D471/04 , C07D487/04 , C07D498/04
Abstract: The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels and calcium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
-
-
-
-
-